
NTUitive
71 Nanyang Drive #03-01, NTU Innovation Centre, Singapore, 638075
Overview
We are the innovation and enterprise company of Nanyang Technological University Singapore (NTU Singapore). We help protect, manage and commercialise the intellectual property (IP) from NTU, support and nurture startups and spinoffs from the university, and develop the university's innovation and enterprise eco-system.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 5
Sector focus
- Education
Investment portfolio
- Pints AI
Participated · Series A · Jun 2026
Pints AI builds Autothought, a platform that plugs into core systems of banks and insurers to automate underwriting, claims, and onboarding while producing a full audit trail for every AI-assisted decision. The platform flags uncertain outputs for human review and is designed to meet requirements of regulators such as the Monetary Authority of Singapore, the Reserve Bank of India, and the Hong Kong Monetary Authority. Pints AI is also developing Autothought Studio, a toolkit intended to let institutions’ engineering teams build and manage AI applications in-house. The company plans to use its $5.6 million pre-Series A raise to expand its engineering team and to build governance and audit capabilities for new regulatory environments. It is pursuing geographic expansion across Asia Pacific and the Middle East. The article did not disclose revenues, user counts, or prior funding details.
- HD
Led · Series A · Apr 2024
HD operates HDmall, a marketplace that aggregates healthcare productized services—from health check-ups and vaccinations to surgeries—helping users find providers, compare options, and access installment payments. The platform lists over 30,000 SKUs from more than 2,500 hospitals and clinics, works with pharmaceutical partners, and serves roughly 400,000 paying customers across Thailand and Indonesia. HD reports about $100 million in annual gross transaction volume and aims to reach 5,000 healthcare providers and 600,000 patients by 2025. The company has built Jib AI, an AI chatbot trained on anonymized product, transaction, and chat-commerce data; roughly 60% of customer interactions are now handled by AI agents. Over the next 12 months HD plans to add order and refund processing, assisted checkouts, scheduling, EHR checking, medical information retrieval, and AI-powered asynchronous virtual care; over two years it plans to expand partnerships with insurers, pharma, employers, and educational institutions. HD also plans geographic expansion into Vietnam and Myanmar in addition to its existing Thailand and Indonesia operations. HD began as a marketplace for third-party healthcare and surgery services (HDmall) and is now building conversational AI tailored to the Southeast Asian healthcare customer journey. The company plans to train chatbots on its proprietary, anonymized transaction, chat, FAQ, and product catalog data gathered over years of operations. HD has worked with roughly 2,000 healthcare providers and reports that 30–40% of its transactions occur through chat commerce. Management aims to roll out a marketplace chatbot within three months and open the technology to third parties by the end of the year, creating a new SaaS revenue stream alongside marketplace commissions. The startup positions its product as vertical, domain-specific AI—“the Sierra AI of the Southeast Asian healthcare industry”—using local data as a competitive moat. During the COVID-19 period HD cut costs, and after the pandemic it moved toward profitability with roughly 2x year-on-year growth; the team accepted a moderate valuation to accelerate growth. HD operates a marketplace for outpatient services and a recently launched private-label surgery service (HDcare) that connects surgeons in private practice, cost-conscious patients, and vacant hospital operating rooms. The platform reports a supply of over 20 operating rooms across Thailand and Indonesia, potential access to more via 1,500 healthcare providers on its marketplace, and over 40 types of surgeries lined up. HD aims to scale HDcare to 200 surgeries performed per quarter by Q4 2023. The company monetizes via transaction cuts, listing fees from providers, and healthcare marketing solutions. Since its founding four years ago and based in Bangkok, HD has served around 250,000 patients and saw 7x sales growth during the pandemic, targeting 2–3x growth in the post-COVID years. HD positions itself as enabling offline medical providers with digital tools rather than competing with them.